Butyric Acid

Butyric Acid

SCHEMBL4774927

CCCC(=O)O.Nc1ccc([Na])cc1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.50
HDAC3 O15379 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
LMNA P02545 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
MAOA P21397 1/20 0.39
TSHR P16473 4/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2C9 P11712 1/20 0.39
PDE4D Q08499 1/20 0.39
MAPT P10636 3/20 0.38
SLC22A6 Q4U2R8 2/20 0.38
SLC22A8 Q8TCC7 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HIF1A Q16665 1/20 0.38
HPGD P15428 1/20 0.37
ALOX5 P09917 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL27716552 0.86 CYP19A1 (0.45) FFAR3LMNACYP1A2CYP3A4MAOA
4-Aminophenol SCHEMBL16670828 0.82 ALDH1A1 (0.52) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL28303316 0.82 HDAC3 (0.56) FFAR3HDAC3HDAC1HDAC2HDAC8
Aniline SCHEMBL7998555 0.82 HDAC3 (0.56) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL27657891 0.81 FFAR3 (0.50) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL11247238 0.81 FFAR3 (0.50) FFAR3HDAC3HDAC1HDAC2HDAC8
4-Chloroaniline SCHEMBL28415706 0.81 FFAR3 (0.50) FFAR3HDAC3HDAC1HDAC2HDAC8
Aniline SCHEMBL29152188 0.80 HDAC3 (0.54) FFAR3HDAC3HDAC1HDAC2HDAC8
Biphenyl-4-Amine SCHEMBL28519772 0.79 SMN1; SMN2 (0.58) FFAR3HDAC3HDAC1HDAC2HDAC8
Bicarbonate SCHEMBL29147443 0.79 MAPT (0.44) LMNACYP3A4TSHRCYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572678-A4 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARM INC (US) 2008-05-07 EP disclosed
EP-1572678-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS Elan Pharmaceuticals, Inc. (US) 2005-09-14 EP disclosed
WO-2004056319-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARMACEUTICALS INC. (US) 2004-07-08 WO disclosed